Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 1709 citations
Electronic publication date
February 21, 2008

View on Pubmed.gov 17823788 | View on doi.org 10.1007/s00125-...

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Search for publications in this journal Diabetologia - 50(11):2374-83

Abstract

AIMS/HYPOTHESIS

Recent evidence suggests that a particular gut microbial community may favour occurrence of the metabolic diseases. Recently, we reported that high-fat (HF) feeding was associated with higher endotoxaemia and lower Bifidobacterium species (spp.) caecal content in mice. We therefore tested whether restoration of the quantity of caecal Bifidobacterium spp. could modulate metabolic endotoxaemia, the inflammatory tone and the development of diabetes.

METHODS

Since bifidobacteria have been reported to reduce intestinal endotoxin levels and improve mucosal barrier function, we specifically increased the gut bifidobacterial content of HF-diet-fed mice through the use of a prebiotic (oligofructose [OFS]).

RESULTS

Compared with normal chow-fed control mice, HF feeding significantly reduced intestinal Gram-negative and Gram-positive bacteria including levels of bifidobacteria, a dominant member of the intestinal microbiota, which is seen as physiologically positive. As expected, HF-OFS-fed mice had totally restored quantities of bifidobacteria. HF-feeding significantly increased endotoxaemia, which was normalised to control levels in HF-OFS-treated mice. Multiple-correlation analyses showed that endotoxaemia significantly and negatively correlated with Bifidobacterium spp., but no relationship was seen between endotoxaemia and any other bacterial group. Finally, in HF-OFS-treated-mice, Bifidobacterium spp. significantly and positively correlated with improved glucose tolerance, glucose-induced insulin secretion and normalised inflammatory tone (decreased endotoxaemia, plasma and adipose tissue proinflammatory cytokines).

CONCLUSIONS/INTERPRETATION

Together, these findings suggest that the gut microbiota contribute towards the pathophysiological regulation of endotoxaemia and set the tone of inflammation for occurrence of diabetes and/or obesity. Thus, it would be useful to develop specific strategies for modifying gut microbiota in favour of bifidobacteria to prevent the deleterious effect of HF-diet-induced metabolic diseases.

References

Eur J Clin Nutr. 2006 May;60(5):567-72

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84

Science. 1993 Jan 1;259(5091):87-91

J Appl Microbiol. 2002;93(1):60-8

Cited by 1709 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice.

Electronic publication date October 22, 2011

Search for publications in this journal PLoS One

Audrey M Neyrinck [...] Nathalie M Delzenne et al.

BACKGROUND

Alterations in the composition of gut microbiota--known as dysbiosis--has been proposed to contribute to the development of obesity, thereby supporting...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Role of the gut microbiota in defining human health.

Electronic publication date June 30, 2010

Search for publications in this journal Expert Rev Anti Infect Ther

Kei E Fujimura [...] Susan V Lynch et al.

The human superorganism is a conglomerate of mammalian and microbial cells, with the latter estimated to outnumber the former by...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances